Quick answers
- What is Diethylpropion hydrochloride used for?
- The FDA-approved label (Diethylpropion Hydrochloride, PD-Rx Pharmaceuticals, Inc., October 15, 2026) says: “Diethylpropion hydrochloride tablets USP, 25 mg are indicated in the management of exogenous obesity as a short-term adjunct (a few weeks) in a regimen of weight reduction based on caloric restriction in patients with an initial body mass index (BMI) of 30 kg/m 2 or higher and who have not responded to appropriate weight reducing regimen (diet and/or exercise) alone. …” This page is not medical advice. Talk to your doctor or pharmacist before you start, stop or change any medicine.
- Does Diethylpropion hydrochloride have a boxed warning?
- No. None of the 23 FDA labels we found for this medicine has a boxed warning.
- Is there a shortage of Diethylpropion hydrochloride?
- No current shortage is listed by the FDA for the products of this medicine (FDA data from October 30, 2026).
- Has Diethylpropion hydrochloride been recalled?
- No recall linked to the products of this medicine appears in the FDA enforcement reports we use.
- Who makes Diethylpropion hydrochloride?
- 12 companies list prescription products of Diethylpropion hydrochloride in the FDA NDC Directory, including NuCare Pharmaceuticals, Inc., Bryant Ranch Prepack and PD-Rx Pharmaceuticals, Inc..
What Diethylpropion hydrochloride is used for
Quoted from the “Indications and Usage” section of the FDA-approved label.
Diethylpropion hydrochloride tablets USP, 25 mg are indicated in the management of exogenous obesity as a short-term adjunct (a few weeks) in a regimen of weight reduction based on caloric restriction in patients with an initial body mass index (BMI) of 30 kg/m 2 or higher and who have not responded to appropriate weight reducing regimen (diet and/or exercise) alone. …
— FDA label: Diethylpropion Hydrochloride, PD-Rx Pharmaceuticals, Inc., effective October 15, 2026. Read the full label on DailyMed →
The FDA has 23 labels for products of this medicine (different makers and forms); uses can differ between them. Check the label that comes with your own medicine.
This page is not medical advice. Talk to your doctor or pharmacist before you start, stop or change any medicine.
Conditions named on the label
These condition names appear word for word in the label’s “Indications and Usage” text (matched with a reviewed table). Each page lists hospitals whose own websites name the condition.
Related medical specialties
Boxed warning
A boxed warning (“black box”) is the FDA’s strongest warning on a drug label, for serious or life-threatening risks.
The label quoted above has no boxed warning.
0 of 23 FDA labels for this medicine have a boxed warning.
Forms and how it is given
| Dosage forms | Tablet · Tablet, extended release |
|---|---|
| Route | Oral |
| Prescription products | 23 in the FDA NDC Directory |
What pharmacies pay (NADAC)
The National Average Drug Acquisition Cost (NADAC) is the average price U.S. retail pharmacies paid to buy one unit of a medicine (one tablet, one mL or one gram), from a monthly survey of pharmacy invoices by the Centers for Medicare & Medicaid Services (CMS). State Medicaid programs use it to pay pharmacies.
This is not the price you pay. What you pay depends on your insurance (copay or coinsurance), your pharmacy and any discounts, and pharmacies also charge for filling a prescription. Ask your pharmacist or your health plan what your price will be.
| Strength and form | Generic or brand | Pharmacies pay |
|---|---|---|
| diethylpropion hydrochloride 25 mg tablet | Generic | $0.2426 per tablet |
| diethylpropion hydrochloride 75 mg tablet, extended release | Generic | $1.98 per tablet |
NADAC list of November 4, 2026; these prices took effect on October 21, 2026. Shown only where a package’s NDC code matches the NADAC list exactly, and only for that exact strength and form: nothing is averaged across strengths. Strengths and forms not listed here have no NADAC price.
Source: NADAC (National Average Drug Acquisition Cost) 2026, data.medicaid.gov (CMS) →
Companies that list this medicine
Labelers in the FDA NDC Directory: the company named on the package (maker or distributor), with the number of prescription products.
- NuCare Pharmaceuticals, Inc.3 products
- Bryant Ranch Prepack3 products
- PD-Rx Pharmaceuticals, Inc.3 products
- Lannett Company, Inc.2 products
- Proficient Rx LP2 products
- A-S Medication Solutions2 products
- Chartwell RX, LLC2 products
- Calvin Scott & Co., Inc.2 products
- DirectRx1 product
- Omnivium Pharmaceuticals LLC.1 product
- Martek Pharmacal Co.1 product
- KVK-Tech, Inc.1 product
FDA approval history
- ANDA: Abbreviated New Drug Application: how a generic version is approved.
Generic approvals (3)
- ANDA201212Avanthi Inc · December 22, 2010
- ANDA200177Lannett Co Inc · July 18, 2011
- ANDA091680Lannett Co Inc · October 24, 2011
Shortage status
The FDA drug shortage list does not show these products.
Recalls
No recall linked to these products (by their NDC code) appears in the FDA enforcement reports.
Official identifiers
| RxCUI (RxNorm) | 978654, 978668 |
|---|---|
| SPL set ID of the quoted label | 5777eed8-c63d-49c4-9dd1-9d087906c368 |
| FDA labels (SPL) | 23 |
| FDA applications | 3 ANDA |
| Active ingredients (FDA) | DIETHYLPROPION |
Sources
- FDA-approved label on DailyMed (National Library of Medicine) — Diethylpropion Hydrochloride, PD-Rx Pharmaceuticals, Inc., effective October 15, 2026; via openFDA, FDA data exported October 30, 2026, retrieved October 31, 2026
- NDC Directory (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drugs@FDA (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drug recall enforcement reports (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 27, 2026, retrieved October 31, 2026
- Drug shortages (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
openFDA data is provided by the FDA as is; it may be incomplete. Always rely on the label that comes with your medicine. FDA Enforcement Report search →